SYNERGY™ XD

Everolimus-Eluting Platinum Chromium Coronary Stent System

SYNERGY XD 48 mm

The FIRST and ONLY 48 mm DES available in the U.S.

Long lesions represent a complex lesion subset that is associated with increased safety related events, reduced efficacy and increased procedure time.¹

Join Our
PCI Community

Directions for Use

Indications, Safety, and Warnings

View the PCI Portfolio

Designed for Complex Cases

Excellent Conformability

Minimizes vessel straightening

*Images courtesy of Belfast City Hospital

Exceptional Overexpansion up to 5.75 mm^†

Enables natural vessel tapering

^† Labeled dilation limit of the 4.0 - 5.0 mm stent models.

Procedural Efficiency

Reduced Treatment Cost

Use one stent vs. two

Reduced Procedure Time

Due to efficiency of single long stent

Reduced Radiation Exposure and Contrast²

Additional safety for you and your patient

Quality Outcomes for Patients

EVOLVE 48 Clinical Trial

1-year results with the SYNERGY 48 mm BP Stent^3‡:

100 patients
15 sites across U.S., Europe, and New Zealand
100% B2/C lesions
27% diabetes mellitus

4.1^%

TLF

0^%

ARC Def/Prob ST

100^%

Technical and Clinical Procedure Success

^‡ Clinical data conducted with SYNERGY 48 mm, SYNERGY XD’s predecessor device, which can be used to illustrate SYNERGY XD 48 mm clinical data

Significantly Lower MACE at 3-Years

With a single stent vs. overlapping stents in the SIRTAX Trial^4§

1.8x

In MACE

( p < 0.01 )

1.7x

In MI^**

1.4x

In ST^**

^§ SYNERGY XD was not evaluated in this trial
** Not statistically significant

Optimal Healing

Find out how synchronous drug elution and polymer absorption enables early healing

SYNERGY Clinical Overview

Discover the clinical evidence on the SYNERGY™ BP Stent, including multiple short DAPT studies

Xtra Deliverability

Learn about the continued advancement in deliverability that SYNERGY XD offers

Top